This opportunity is no longer accepting applications.
grant PA-25-174

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) is offering funding for R01 research projects that use advanced cancer biology techniques to investigate how different types of radiation in radionuclide-based therapies, like radiopharmaceutical therapy, affect normal tissue, tumor cells, and the surrounding tumor environment.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types of radiation used in radionuclide-based therapeutics (e.g., radiopharmaceu…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute

Dates

Opportunity Released: November 18, 2024
Submission Deadline: May 7, 2025
Application Window Closes: May 7, 2025
Open for Submission: November 18, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.